Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.45 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 8/20 | 0.42 |
| ▸ | CNR1 | P21554 | 6/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4888284 | 1.00 | TSHR (0.48) | TSHRAKT1SOAT1CNR2CNR1 | |
| SCHEMBL19289868 | 0.88 | TSHR (0.52) | TSHRSOAT1CNR2CNR1PPARG | |
| SCHEMBL1759110 | 0.87 | — | — | |
| SCHEMBL1759112 | 0.87 | — | — | |
| SCHEMBL10049011 | 0.86 | SOAT1 (0.45) | TSHRAKT1SOAT1CNR2CNR1 | |
| SCHEMBL1874939 | 0.86 | SOAT1 (0.45) | TSHRAKT1SOAT1CNR2CNR1 | |
| SCHEMBL1874937 | 0.86 | SOAT1 (0.45) | TSHRAKT1SOAT1CNR2CNR1 | |
| SCHEMBL23706440 | 0.83 | TSHR (0.52) | TSHRAKT1PPARGPPARDPPARA | |
| SCHEMBL3084656 | 0.83 | TSHR (0.52) | TSHRAKT1PPARGPPARDPPARA | |
| SCHEMBL21594794 | 0.83 | TSHR (0.52) | TSHRAKT1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117154213-A | Viscoelastic conductive polymer electrolyte, preparation method thereof and lithium metal semi-solid battery | 四川启睿克科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-117154213-A | Viscoelastic conductive polymer electrolyte, preparation method thereof and lithium metal semi-solid battery | 四川启睿克科技有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20140341909-A1 | CONJUGATION OF BIOMOLECULES USING DIELS-ALDER CYCLOADDITION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV (US) | 2014-11-20 | — | — | US | disclosed |
| US-20080008709-A1 | Conjugation of biomolecules using Diels-Alder cycloaddition | The Government of the U.S. as represented by the Secretary of the Dept. of Health and Human | 2008-01-10 | — | — | US | disclosed |
| US-7211445-B2 | Immunology, diagnosis, therapy; complex of carbohydrate and protein; immobilization | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-05-01 | — | — | US | disclosed |
| US-20040082067-A1 | Immunology, diagnosis, therapy; complex of carbohydrate and protein; immobilization | THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HLTH. AND HUMAN SERVICE | 2004-04-29 | — | — | US | disclosed |
| US-6673905-B2 | FOR COVALENTLY LINKING CARBOHYDRATES AND PROTEINS UNDER NEUTRAL CONDITIONS, BY ATTACHING DOUBLE BONDS TO A CARRIER PROTEIN, AND ATTACHING A CONJUGATED DIENE TO A CARBOHYDRATE HAPTEN, THEN COUPLING; VACCINES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-01-06 | — | — | US | disclosed |
| US-20020068818-A1 | Conjugation of biomolecules using diels-alder cycloaddition | POZSGAY VINCE (US) | 2002-06-06 | — | — | US | disclosed |
| US-20020051788-A1 | For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines | HEALTH AND HUMAN SERVICES, DEPARTMENT OF, GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, THE | 2002-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140341909-A1 | CONJUGATION OF BIOMOLECULES USING DIELS-ALDER CYCLOADDITION | DERA, DCLRE1A, CD2BP2 | TSHR 2843/4885AKT1 3561/4885SOAT1 1386/4885 |
| US-20020068818-A1 | Conjugation of biomolecules using diels-alder cycloaddition | DERA, DCLRE1A, CD2BP2 | TSHR 2843/4885AKT1 3561/4885SOAT1 1386/4885 |
| US-20020051788-A1 | For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines | DCLRE1A, DERA, LY96 | TSHR 3303/4885AKT1 3007/4885SOAT1 1154/4885 |
| US-20080008709-A1 | Conjugation of biomolecules using Diels-Alder cycloaddition | DERA, DCLRE1A, CD2BP2 | TSHR 2843/4885AKT1 3561/4885SOAT1 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.